US Q3 Health And Wellness Results: Chromadex, Lannett, Mannatech And USANA
ChromaDex trims loss, adds Nestle as Niagen customer; currency exchange slams Mannatech; Asia-Pacific sales, currency exchange Rock USANA results; and Lannett sees upsides after 25% sales slide.
You may also be interested in...
ChromaDex Rides Nestle Deal To 14% Q4 Growth; Mannatech, USANA End Year In Slumps
ChromaDex reports Niagen ingredient sales growth propelled by upfront minimum purchase from Nestlé Health Science; and Mannatech and USANA both reported larger full-year sales dips after ending 2022 in slumps.
ChromaDex Promotes Gerber To CFO
Gerber was serving as interim CFO. She has more than 20 years’ experience in investment management and investor relations and finance, including strategic planning, operational efficiency programs and capital market transactions.
HBW Market News: Mannatech Thailand, Clariant China, CHPA Pain Relief Quiz, CRN Board
Mannatech launches in Thailand; China facility becoming Clariant’s global health care support hub; Signs in Dollar General stores link to CHPA online pain relief product quiz; and Nutrawise counsel elected CRN board chair.